Indefinite Delivery Contract SPE2DU25D2227

The federal contract IDV award SPE2DU25D2227 is an Indefinite Delivery Contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a comprehensive range of pharmaceutical products and medical supplies in support of military healthcare programs globally. The contract, valued at up to $4,999,999, covers an extensive array of medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The contract has a base period of 30 months and three 30-month option periods, with an estimated total value of $30.3 billion across all awarded contracts.

This IDC serves as a primary vehicle for the DLA to efficiently procure essential pharmaceutical and medical supplies to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract is the result of a pre-solicitation announced by the DLA Troop Support Medical Supply Chain, which plans to issue a solicitation in March 2024 to establish Pharmaceutical Prime Vendor Global Program Generation V contracts. The solicitation will be unrestricted and fully competitive, with the intent to make multiple regional awards to ensure resilience and access to vital pharmaceuticals during contingencies or natural disasters.